Amos C I, Laing A E
Genetic Studies Section, NIAMS, Bethesda, MD 20892.
Genet Epidemiol. 1993;10(6):671-6. doi: 10.1002/gepi.1370100657.
A variety of robust and model-dependent genetic linkage methods were applied to log transformed lipid levels from a large pedigree in which the LDL receptor defect has been shown to segregate by molecular biologic techniques. Application of the Haseman-Elston and a variance-components based test for linkage identified LDL and cholesterol as cosegregating with the marker C3, which is genetically linked to the LDL receptor defect. Consideration of lipid fractions as a multivariate response identified (0.723 x cholesterol) - (0.551 x triglycerides) as most strongly supporting evidence for linkage with C3. Subsequent segregation and linkage analyses provided support for an autosomal dominant major gene influencing either LDL or the function of cholesterol and triglycerides. Genetic linkage to LDL was only mildly supported, with a maximum lod score of 0.51 at a recombination fraction of theta = 0.33. Genetic linkage of the linear function to C3 was more strongly supported, with a maximum lod score of 1.69 at theta = 0.09. Bivariate analysis of clinical affection (with either type IIa or type IIb hyperlipidemia) and quantitative measures (LDL or the linear function) generally led to decreased lod scores, indicating, in this pedigree, loss of information when using clinical affection.
多种稳健且依赖模型的遗传连锁方法被应用于一个大型家系经对数转换后的血脂水平,在该家系中,低密度脂蛋白(LDL)受体缺陷已通过分子生物学技术证明是可分离的。应用哈斯曼 - 埃尔斯顿方法以及基于方差成分的连锁检验,确定低密度脂蛋白和胆固醇与标记物C3共分离,而C3在基因上与低密度脂蛋白受体缺陷相关联。将血脂成分视为多变量反应时,确定(0.723×胆固醇) - (0.551×甘油三酯)为与C3连锁的最有力支持证据。随后的分离和连锁分析支持了一个常染色体显性主基因影响低密度脂蛋白或胆固醇及甘油三酯的功能。与低密度脂蛋白的遗传连锁仅得到微弱支持,在重组率θ = 0.33时,最大对数优势分数为0.51。线性函数与C3的遗传连锁得到更强支持,在θ = 0.09时,最大对数优势分数为1.69。对临床病症(IIa型或IIb型高脂血症)和定量指标(低密度脂蛋白或线性函数)进行双变量分析,通常会导致对数优势分数降低,这表明在这个家系中,使用临床病症时会出现信息丢失。